{
  "id": 26427,
  "name": "Eugit Therapeutics",
  "slug": "eugit-therapeutics",
  "former_names": [
    "EUGIT Tx",
    "EUGIT Therapeutics",
    "Eugit",
    "Eugit Therapeutics Inc"
  ],
  "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/a88b74cc086730f852f068c605f2dcaa54b40a16.png",
  "website": "http://www.eugittx.com",
  "all_locations": "San Carlos, CA, USA; South San Francisco, CA, USA",
  "long_description": "Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical trials within two years.\r\n\r\nCofounded by George Church (Harvard) and funded by Y Combinator (S22).",
  "one_liner": "Enabling Tissue Targeting of Therapies",
  "team_size": 2,
  "industry": "Healthcare",
  "subindustry": "Healthcare -> Therapeutics",
  "launched_at": 1656718658,
  "tags": [
    "Cell Therapy",
    "Synthetic Biology",
    "Therapeutics",
    "Oncology",
    "Biotechnology"
  ],
  "tags_highlighted": [],
  "top_company": false,
  "isHiring": false,
  "nonprofit": false,
  "batch": "S22",
  "status": "Active",
  "industries": [
    "Healthcare",
    "Therapeutics"
  ],
  "regions": [
    "United States of America",
    "America / Canada"
  ],
  "stage": "Early",
  "app_video_public": false,
  "demo_day_video_public": false,
  "app_answers": null,
  "question_answers": false,
  "url": "https://www.ycombinator.com/companies/eugit-therapeutics",
  "api": "https://yc-oss.github.io/api/batches/s22/eugit-therapeutics.json"
}
